Oregon Health and Science University (CHH2) — Portland, Oregon

Oregon Health and Science University (CHH2) is a clinical research site located in Portland, Oregon, United States 97239.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Oregon Health and Science University (CHH2) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Carcinoma, Non-Small-Cell Lung.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Oregon Health and Science University (CHH2)?

Oregon Health and Science University (CHH2) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Oregon Health and Science University (CHH2) conducted?

Oregon Health and Science University (CHH2) has 1 clinical trials on record, with 1 currently active. Their work covers Carcinoma, Non-Small-Cell Lung.

Is Oregon Health and Science University (CHH2) accredited by Crixeo Health?

Oregon Health and Science University (CHH2) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Oregon Health and Science University (CHH2)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.